Invasive Fungal Infections in Decompensated Cirrhosis: A Clinical Case Series and Its Prognostic Implications

Authors

  • Juan Francisco Maag Hepatology & Liver Transplant Unit, Hospital El Cruce de Florencio Varela. https://orcid.org/0009-0002-5638-4915
  • Ignacio Roca Hepatology & Liver Transplant Unit, Hospital El Cruce de Florencio Varela. https://orcid.org/0009-0007-6374-6837
  • Lucía Navarro Hepatology & Liver Transplant Unit, Hospital El Cruce de Florencio Varela.
  • Manuel Barbero Hepatology & Liver Transplant Unit, Hospital El Cruce de Florencio Varela. https://orcid.org/0000-0002-5957-7213
  • Nicolás Domínguez Hepatology & Liver Transplant Unit, Hospital El Cruce de Florencio Varela. https://orcid.org/0009-0001-9929-2060
  • Omar Galdame Hepatology & Liver Transplant Unit, Hospital El Cruce de Florencio Varela.
  • Fernando Cairo Hepatology & Liver Transplant Unit, Hospital El Cruce de Florencio Varela. https://orcid.org/0000-0003-2480-417X

DOI:

https://doi.org/10.52787/agl.v55i3.517

Keywords:

Cirrhosis, candida albicans, cryptococcus neoformans, model for end-stage liver disease-sodium, acute-on-chronic liver failure, in-hospital mortality

Abstract

Introduction and Objectives. Systemic fungal infections are an under-recognized cause of morbidity and mortality in patients with decompensated liver cirrhosis. Our goal was to describe the clinical features, microbiological findings, and outcomes of invasive fungal infections in this population in the context of a liver transplant center.

Materials and Methods. We conducted a retrospective observational study of 16 adult patients with decompensated cirrhosis and culture-proven invasive fungal infections diagnosed between 2013 and 2024. Data were collected from electronic medical records and microbiology databases. Fungal pathogens were isolated from blood or ascitic fluid cultures. We analyzed demographics, cirrhosis etiology, antifungal treatment, and outcomes.

Results. The mean age was 41 years, and 50% of patients were female. All patients had decompensated cirrhosis and a mean model for end-stage liver disease-sodium score of 25.7. Half of them met criteria for acute-on-chronic liver failure at diagnosis. The most frequent isolates were Candida albicans (37.5%) and Cryptococcus neoformans (37.5%). Ascites was present in 87.5% of patients; and 68.8% had received antibiotics, while 31.2% had received corticosteroids, within 30 days prior to diagnosis. In-hospital mortality was 62.5%, with a median survival of 11 days.

Conclusions. Invasive fungal infections in decompensated cirrhosis are associated with high short-term mortality and often occur in patients who have been exposed to antibiotics or corticosteroids. Awareness of this complication and prompt initiation of antifungal treatment may improve outcomes. Multicenter studies are needed to define risk factors and optimize diagnostic and therapeutic strategies.

References

-1. Playford EG, Lipman J, Jones M, Lau A, Sorrell TC. Problematic dichotomization of risk for intensive care unit (ICU)-acquired invasive candidiasis: Results using a risk-predictive model to categorize three levels of risk from a multicenter prospective cohort of Australian ICU patients. Clin Infect Dis. 2016;63(11):1463-1469. https://doi.org/10.1093/cid/ciw577

-2. Nolla Salas J, Rodríguez A, Olaechea Astigarraga PM, Prieto Prieto J, Almirante Grajera B. Epidemiología de la infección fúngica en el paciente crítico no granulocitopénico. Med Intensiva. 2005;(Supl. 3):4-11.

-3. Albillos A, Lario M, Álvarez-Mon M. Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance. J Hepatol. 2014;61(6):1385-1396. https://doi.org/10.1016/j.jhep.2014.08.010

-4. Lahmer T, Messer M, Rasch S, Sulser F, Schmid RM, Huber W. Invasive mycosis in medical intensive care unit patients with severe alcoholic hepatitis. Mycopathologia. 2014;177(3-4):193-197. https://pubmed.ncbi.nlm.nih.gov/24710759/

-5. Bajaj JS, Liu EJ, Kheradman R, Fagan A, Heuman DM, White MB, et al. Fungal dysbiosis in cirrhosis. Gut. 2018;67(6):1146-1154. https://pubmed.ncbi.nlm.nih.gov/28578302/

-6. Li B, Xu W, Lin R, Zhou M, Lin W, Lin J, et al. Spontaneous fungal ascites infection in patients with cirrhosis: An analysis of 10 cases. Infect Dis Ther. 2021;10(2):1013-1023. https://pubmed.ncbi.nlm.nih.gov/33709385/

-7. Tariq T, Iqbal S, Perumpail BJ, Shah ND, Ahmed A, Cholankeril G. Spontaneous fungal peritonitis: Micro-organisms, management and mortality in liver cirrhosis-a systematic review. World J Hepatol. 2019;11(4):406-418. https://pubmed.ncbi.nlm.nih.gov/31388401/

-8. Lahmer T, Peçanha-Pietrobom PM, Schmid RM, Colombo AL. Invasive fungal infections in acute and chronic liver impairment: A systematic review. Mycoses. 2021;65(2):140-151. https://pubmed.ncbi.nlm.nih.gov/34837414/

-9. Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, Raoul JL, et al. EASL clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182-236. https://doi.org/10.1016/j.jhep.2018.03.019

-10. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. EASL clinical practice guidelines on acute-on-chronic liver failure. J Hepatol. 2023;79(2):461-491. https://pubmed.ncbi.nlm.nih.gov/37364789/

-11. Fernández J, Acevedo J, Wiest R, Gustot T, Amoros A, Deulofeu C, et al. Bacterial and fungal infections in acute-on-chronic liver failure: Prevalence, characteristics and impact on prognosis. Gut. 2018;67(10):1870-1880. https://doi.org/10.1136/gutjnl-2017-314240

-12. Bassetti M, Righi E, Montravers P, Cornely OA, Leroy O, Eckmann C, et al. Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: A multicenter study. Intensive Care Med. 2017;43(4):509-518. https://pubmed.ncbi.nlm.nih.gov/28271321/

-13. Lahmer T, Messer M, Rasch S, Sulser F, Schmid RM, Huber W. Invasive mycosis in medical ICU patients with severe alcoholic hepatitis. Mycopathologia. 2014;177(3-4):193-197. https://pubmed.ncbi.nlm.nih.gov/24710759/

-14. Hassan EA, Abd El-Rehim ASD, Hassany M, Abd El-Fattah MR, Zaki MM, Al-Adl MA. Fungal infection in patients with end-stage liver disease: Low frequency or low index of suspicion? Int J Infect Dis. 2014;23:69-74. https://pubmed.ncbi.nlm.nih.gov/24726663/

-15. Hwang SY, Lee JH, Lee JH, Lee SY, Lee HJ, Park JH. Spontaneous fungal peritonitis: A severe complication in patients with advanced liver cirrhosis. Eur J Clin Microbiol Infect Dis. 2014;33(2):259-264. https://pubmed.ncbi.nlm.nih.gov/23996048/

-16. Alexopoulou A, Vasilieva L, Kanellopoulou T, Archimandritis AJ. Fungal infections in patients with cirrhosis. J Hepatol. 2015;63(4):1043-1045. https://pubmed.ncbi.nlm.nih.gov/26095180/

-17. Barbero M, Burgos S, Roca I, Navarro L, Cairo F. Immunosuppressive treatment in autoimmune decompensated cirrhosis, when to say enough: A retrospective analysis. Medicine (Baltimore). 2025;104(6):e41378. https://pubmed.ncbi.nlm.nih.gov/39928808/

Downloads

Published

2025-09-30

How to Cite

Maag, J. F., Roca, I., Navarro, L., Barbero, M., Domínguez, N., Galdame, O., & Cairo, F. (2025). Invasive Fungal Infections in Decompensated Cirrhosis: A Clinical Case Series and Its Prognostic Implications. Acta Gastroenterológica Latinoamericana, 55(3). https://doi.org/10.52787/agl.v55i3.517

Issue

Vol. 55 No. 3 (2025): Acta Gastroenterológica Latinoamericana

Section

Original Articles

License

Copyright (c) 2025 Juan Francisco Maag, Ignacio Roca, Lucía Navarro, Manuel Barbero, Nicolás Domínguez, Omar Galdame, Fernando Cairo

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.